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Summary
Objective: Proliferation and chondrogenic commitment of cultured articular chondrocytes are impaired when cells derive from aged donors. In
those subjects the feasibility of cell-based therapies for articular surface repair is reduced. Moreover, the use of serum as medium supplement
elicits non-physiological responses in cultured chondrocytes. This study was therefore undertaken to identify the expansion culture conditions
needed to sustain growth and chondrogenic commitment of chondrocytes harvested from aged human subjects.
Design: Articular cartilage was obtained from aged (69e75 years) and from young adult subjects (27e35 years). Chondrocytes were isolated
and cultured in serum-free (SF) or in serum-supplemented [fetal calf serum (FCS)] conditions. Chondrocytes were expanded in monolayer for
ﬁve duplications and processed for RNA extraction and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. The
differentiation potential was assessed by micromass pellet cultures before and after expansion in either culture medium, or after a prolonged
exposure to serum followed by a period in SF condition.
Results: Only SF-cultured chondrocytes reached ﬁve duplications within 25e35 days, maintaining the expression of some chondrogenic
markers and without altering the levels of active matrix metalloproteinase 3 (MMP-3). Only the pellets derived from SF-expanded cultures
positively stained for cartilage matrix deposition. On the contrary, exposure to serum diminished the proliferation capacities, abolished the
differentiation potential in the same cells and elicited transcription of the MMP-3 gene. Shifting culture conditions from FCS to SF resumed
growth rates but proper extracellular matrix deposition was only partially restored.
Conclusions: The SF conditions have proven valuable to prime cell proliferation and to sustain proper commitment in chondrocytes from aged
patients. This culturing approach may represent a therapeutic chance extendable to a range of patients normally excluded from clinical
protocols based on autologous chondrocyte implantation (ACI).
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Articular cartilage lesions, both of traumatic or pathological
origin, do not heal spontaneously and often undergo
progressive degeneration towards osteoarthritis (OA). Fre-
quently, the only effective treatment for pain reduction and
knee disability in elderly patients is prosthetic joint re-
placement1,2. However, this successful but invasive ap-
proach implies severe surgical treatments and not always
provides long-term joint functionality due to the limited life
span of the prostheses3,4. Since the ﬁrst autologous
chondrocyte implantation (ACI) in patients with localized
traumatic lesions in the cartilage surface of the knee3,
continuous efforts have been made to improve the quality of
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Received 7 May 2004; revision accepted 19 February 2005.58the repaired tissue and to upgrade the surgical techni-
ques5e7. New arthroscopy devices have been recently
developed, taking advantage of bioengineered scaffolds as
cell delivery systems8,9. This potential improvement of the
ACI technique can be tested in animal models or in the
context of clinical trials. However, the protocols of those trials
usually enforce age-restrictions in patient selection. Indeed,
the proliferation capacity and the chondrogenic commitment
of cultured chondrocytes are impaired when the primary cells
are derived from aged patients10e12. Thus, in those subjects
who represent the largest clinical target, the feasibility of
a cell-based therapy is clearly reduced. In addition, classical
culture conditions include serum (autologous, or bovine, if for
research purposes) as a medium supplement; this may elicit
non-physiological responses in cultured chondrocytes13
since cartilage in vivo is deprived of serum and relies only
on autocrine and paracrine factors for homeostasis.
This study was therefore undertaken to identify the
culture conditions needed during expansion to sustain
the proliferation and to maintain the chondrogenic9
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main goal was to preserve the native biological properties
and responsiveness of the expanded cells in view of their
clinical application for cartilage repair in this sub-population
of patients.
Methods
BIOPTIC SPECIMENS AND CHONDROCYTE ISOLATION
Bioptic material was collected from the femoral condyles
of ﬁve elderly patients (1 male and 4 females; age
comprised between 69 and 75 years) undergoing total
knee arthroplasty. Control specimens were also obtained
from young patients (1 male and 2 females; age comprised
between 27 and 35 years) undergoing reparative surgery
following knee trauma. All patients had signed an informed
consent approved by the Ethical Committee of the San
Antonio Hospital, Recco, Italy. Cartilage was cleared of
connective tissue and/or subchondral bone, minced in small
fragments and rinsed in fresh phosphate-buffered saline
(PBS, pH 7.2). Single chondrocytes were released by
repeated enzymatic digestions (1 mg/mL hyaluronidase,
400 U/mL collagenase I, 1000 U/mL collagenase II, 0.25%
trypsin in PBS) at 37(C. The primary cells were pooled,
counted and seeded. The culture dishes, for all the culturing
conditions and throughout the entire experiment, were pre-
coated for 24 h with 10% fetal calf serum (FCS) in culture
medium (Coon’s modiﬁed Ham’s-F12; Biochrom A.G.,
Berlin, Germany) to allow attachment of the serum
ﬁbronectin to the plastic. Before use for cell plating, the
dishes were thoroughly washed three times in PBS to
remove any residual trace of serum. The primary chon-
drocytes were kept in FCS-containing medium for 48 h and
then enzymatically detached, collected, washed in fresh
PBS, counted and cultured as described below.
CULTURE CONDITIONS AND CELL EXPANSION
Human articular chondrocytes (HACs) from each donor
were divided into equivalent aliquots; one aliquot was grown
in F12 supplemented with 10% FCS, the other one in
a serum-free (SF) formulation. The SF medium was
adopted, with minor modiﬁcations, from our previous
report13, and is summarized in Table I. For each condition,
medium was changed three times a week. Cell passaging
and counting was performed at sub-conﬂuence. Once
HACs had reached ﬁve doublings, they were trypsinized
to extract total RNA and/or used for micromass cultures, to
evaluate respectively the expression of cartilage markers
and the residual chondrogenic potential after expansion.
Alternatively, cells were cultured for 1 month in FCS,
keeping tracks of the number of duplication performed, and
then transferred to the SF-culture conditions (FCS/SF).
Once ﬁve overall doublings were reached, cells were
processed as indicated above. Whenever indicated, Trans-
forming Growth Factor b-1 (TGF b-1; Peprotech Inc.,
London, UK) was added to the SF medium to a ﬁnal
concentration of 10 ng/mL. Alternatively, retinoic acid (RA;
All-trans RA; SigmaeAldrich Inc., St. Louis, MO, USA) was
added to the FCS cultures every other day, for 7 days to the
ﬁnal concentration of 500 nM.
GROWTH KINETICS
For growth kinetic experiments, 5! 103 primary cells
were seeded in 10% FCS-coated 24-well plates and
maintained in minimal F12 medium for 24 h. Then mediumwas changed and the appropriate supplement (FCS or
SF) was added to the cultures to resume proliferation.
Growth was evaluated at different time intervals using the
Thiazolyl Blue staining (MTT; SigmaeAldrich Inc) the
absorbance of which correlates to cell number. Cell
doublings were calculated with respect to the starting cell
number. The number of duplications was plotted vs time to
express growth rate as a function of the culture conditions.
Each time-point was assessed in triplicate.
TOTAL RNA EXTRACTION AND SEMI-QUANTITATIVE REVERSE
TRANSCRIPTASE-PCR
Semi-quantitative reverse transcriptase-polymerase
chain reaction (RT-PCR) was performed as previously
described14. Total RNA was extracted with the RNeasy Mini
Kit (Qiagen GmbH, Hilden, Germany). The Gene Amp RNA
PCR Kit (Applied Biosystems, Foster City, CA, USA) was
used to assess the levels of transcripts for type I collagen,
type II collagen, aggrecan, cartilage oligomeric matrix
protein (COMP) and the housekeeping enzyme glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH). Primer sets
for each gene were derived from published sequences and
were designed to perform at the same cycling conditions14.
The level of the cartilage-speciﬁc transcription factor
Sox913,15,16 was also analyzed. Ampliﬁed products were
resolved on 1% agarose gels, stained with ethidium
bromide and photographed under UV light.
REAL-TIME QUANTITATIVE PCR
Matrix metalloproteinase 3 (stromelysin-1/MMP-3) mRNA
levels were assessed by real-time quantitative RT-PCR,
using the PE ABI Prism 7700 Sequence detection System
(PE Applied Biosystems). The expression of the MMP-3
gene and of the housekeeping calibrator GAPDH gene was
assessed in parallel. The Primer Express, version 1.5
software was used to generate from the human MMP-3
mRNA coding sequence (accession number NM_002422)
a speciﬁc TaqMan probe and the forward and reverse
oligonucleotides (Table II). The probe appropriately encom-
passed an exon/exon junction to avoid ampliﬁcation of
contaminant genomic DNA. The threshold cycle (Ct) was
deﬁned as the cycle number at which the ﬂuorescent
reporter emission increased above a threshold level, as
deﬁned by the ABI Prism 7700 standard settings, at which
Table I
SF medium composition
Component Final concentration in
Coon’s modiﬁed
Ham’s-F12
Ascorbic Acid 250 mM
Linoleic Acid 4.5 mM
Cholesterol 13 mM
Dexamethasone 10 nM
N-acetylcysteine 50 mM
Apo-Transferrin 25 mg/mL
Holo-Transferrin 25 mg/mL
Sodium Selenite 30 nM
Sodium Pantothenate 17 mM
Biotin 33 mM
Insulin 10 mg/mL
Epidermal Growth Factor 5 ng/mL
Fibroblast Growth Factor 2 5 ng/mL
Platelet Derived Growth Factor 5 ng/mL
Human Serum Albumin 1%
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Standard curves were generated for each gene by
assessing serial cDNA dilutions. Relative transcript levels,
for each condition, were then calculated from the appropri-
ate standard curve and normalized to the corresponding
target quantity of the calibrator. The analysis was performed
on three different HACs, each cultured both in FCS and SF
conditions. Six and ﬁve duplicates of each RNA sample
were tested for MMP-3 and GAPDH, respectively.
ZYMOGRAPHIC ANALYSIS OF METALLOPROTEINASES
Conditioned medium of HACs cultures was collected from
both culture conditions (FCS and SF) when the cells had
reached ﬁve duplications. Protein content was assessed in
aliquots of each different medium with the Protein Assay
Reagent Kit (BioRad, Hercules, CA, USA). Equal amounts
of proteins were loaded on 12.5% sodium dodecyl-sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) gels co-
polymerized with 1.6 mg/mL gelatin (SigmaeAldrich Inc.),
as described by Chen et al.17.
WESTERN BLOT ANALYSIS
Equal amounts of proteins (20 mg/sample) from each
conditioned medium were also loaded on standard
4e12% NU-PAGE gradient gels (Invitrogen S.r.l., Milano,
Italy). Blotting onto Protran nitrocellulose membranes
(Schleicher&Schuell, Dassel, Germany) was performed
in the X-Cell Sure Lock Electrophoresis Cell (Invitrogen
S.r.l.), according to the manufacturer’s instructions. The
membranes were saturated overnight in 3% non-fat milk in
tris/tween buffered solution (TTBS) buffer (500 nM NaCl;
20 mM Tris/Cl, pH 7.5; 0.05% Tween-20) and incubated
for 3 h at room temperature with the anti-human MMP-3
pro-protein (Anti-MMP-3 Rabbit polyclonal antibody
M5202; SigmaeAldrich Inc.). The antibody recognized
the latent form of the protein at 59/57 kDa. The
immunoreactive band was revealed by an alkaline
phosphate conjugated afﬁnity-puriﬁed monoclonal anti-
rabbit mouse IgG (SigmaeAldrich Inc.) and the alkaline
phosphatase substrate BICP/NBT (ICN Biomedicals,
Aurora, OH, USA).
MICROMASS CULTURE
Maintenance of the chondrogenic potential was tested by
means of an in vitro assay of cartilage formation in a high-
cell density micromass culture. Brieﬂy, 2.5! 105 cell
aliquots (either from FCS, SF, FCS/ SF-expanded cells
or freshly prepared chondrocytes) were pelleted by centri-
fugation and cultured in a deﬁned chondrogenic medium for
2 weeks as previously reported by Johnstone et al.18. The
resulting pellets were then processed for histological and
immunohistochemical analyses.
HISTOLOGY AND IMMUNOHISTOCHEMISTRY
The high-density pellets were ﬁxed in 4% formaldehyde
in PBS, washed twice in PBS for 15 min and then
Table II
Oligonucleotides and TaqMan probe sequences used in the
quantitative real-time RT-PCR
Forward 5#-ggAgTTCCTgATgTTggTCACTTC-3#
Reverse 5#-AgAAAACCgTTTAgACCACATATTAAg-3#
Probe 5#-TET-TggAggAAAACCCACCTTACATACAgg
ATTg-TAMRA-3#parafﬁn-embedded. Sections (5 mm thickness) were cut,
dewaxed and stained with Toluidine Blue, Alcian Blue and
Safranin-O to evidence cartilage matrix components. Two
sections at two different levels were cut and stained for
each sample.
Deposition of human type I and type II collagens was
assessed with the SP1.D8 and CIICI monoclonal antibodies,
respectively (Developmental Studies Hybridoma Bank, De-
partment of Biological Sciences, University of Iowa, Iowa
City, IA, USA). After standard dewaxing and extensive
washings in PBS, pellet sections were incubated with goat
serum for 30 min and then for 2 h with the primary antibodies.
A secondary incubation with a biotineconjugated AfﬁniPure
anti-mouse goat IgM (m-chain speciﬁc; Jackson ImmunoR-
esearch Laboratories Inc., West Groove, PA, USA) was
followed by revelation with peroxidase-conjugated strepta-
vidin (Jackson ImmunoResearch Laboratories Inc.).
Results
In this study we compared the effects of two different
culturing conditions, FCS and SF, on chondrocytes derived
from aged patients, evaluating their morphology, markers
expression, re-differentiation potential and MMP-3 levels.
Results from the two culturing conditions were confronted
within each primary culture, therefore avoiding any bias due
to the individual variability between donors. We are aware
that samples derived from aged patients, even in regions of
‘‘normal’’ appearing cartilage, are metabolically not truly
normal10e12, but still it remains that these aged cells are the
ones to be expanded and reimplanted if the ACI protocol is
to be extended to elderly patients.
MORPHOLOGY AND GROWTH KINETICS OF HACs
By contrast to serum supplement, the SF-culture condi-
tion induces clear morphological changes in chondrocytes
expanded in monolayer (Fig. 1, compare panels A and B),
independently of the age of the donor. After ﬁve duplica-
tions, chondrocytes cultured in SF had already assumed
a spindle elongated ‘‘ﬁbroblast-like’’ phenotype, whereas
those cultured in FCS maintained a more polygonal
morphology. Interestingly, within 35 days in SF medium,
chondrocytes from aged donors can already achieve ﬁve
duplications (corresponding to a 16-fold increase of the
starting cell number), whereas it takes 3e4 months to
perform the same number of doublings if cells from the
same donor are grown in the presence of FCS. It should be
noted, though, that in the SF condition, elderly patients’
cells duplicate more slowly than cells from young subjects
[compare the plain and the dotted curve in Fig. 1(C)].
Whenever chondrocytes were grown in the presence of
10% FCS for 35 days and then transferred to the SF
medium, proliferation was rapidly resumed, as evidenced
by the slope of the interpolation curves [Fig. 1(D), dashed
and dotted lines for FCS/ SF and SF, respectively],
thereby indicating active responsiveness of the cells to the
medium composition and to the mitogenic effects of the
growth factors available in the environment.
EXPRESSION OF CHONDROGENIC MARKERS IN MONOLAYER
During the expansion phase, the levels of several
transcripts were assessed by means of RT-PCR, as
shown in Fig. 2. Up-regulation of type I collagen and
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Fig. 1. Morphology and growth kinetics of HACs harvested from aged patients. (A) and (B): Morphology of chondrocytes from the same
primary culture expanded for ﬁve doublings in FCS or in SF, (A) and (B), respectively. Pictures, taken at the same magniﬁcation, are
representative of all the cultures used in this study. (C): Number of cell duplications vs time in SF and in FCS culture conditions. The dashed
curve depicts the results obtained in FCS conditions, the solid curve those obtained in SF conditions. The dotted curve (young subjects) is
used as reference control (see also Ref.13). Correlation coefﬁcient values (R2), S.D. bars and n values for each curve are also indicated. (D):
Number of cell duplications vs time in FCS cultures transferred to SF conditions. Cells were shifted to SF conditions after 35 days of expansion
in a 10% FCS supplemented medium (arrow). The dashed line represents the FCS/SF interpolation after medium shift; the dotted line
refers to the SF results as presented in panel C.down-regulation of type II collagen were evidenced, both in
FCS and SF cultures. At variance with FCS, the SF medium
also induced a reduction of the aggrecan transcript level in
a time-dependent fashion (Fig. 2; compare lane T0, SF at
2.5 and 5.0 doublings). A clear loss of the COMP transcripts
was also observed already at 2.5 doublings in SF but not in
FCS. The addition of TGF b-1 to the SF medium seemseffective at maintaining some transcript levels closer to the
ones in primary chondrocytes (Fig. 2, compare lanes T0, 2.5
and 2.5CTGF b-1 in the SF condition for aggrecan, COMP
and type II collagen). Interestingly, a marked reduction of
Sox9 mRNA was shown in the FCS-cultured cells, as
evidenced after ﬁve doublings. This event was not present
in the SF cultures where the Sox9 transcript level remained
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Fig. 2. RT-PCR analysis of chondrogenic marker genes. For each panel the gene analyzed and the expected size of the ampliﬁed DNA
fragment are indicated on the right side. M: DNA molecular weight markers (in base pairs); T0: freshly isolated chondrocytes; FCS: HACs
cultured in 10% FCS up to ﬁve doublings; SF: HACs cultured in SF conditions up to 2.5 or 5 doublings, as indicated;CTGF b-1: HACs cultured
in SF conditions supplemented with TGF b-1 (10 ng/mL) during the expansion phase, up to 2.5 doublings. Results are representative of all the
HACs tested in each culture condition.unchanged even in the presence of TGF b-1. It should be
noted that the relative levels of Sox9 varied among donors,
but in any case they decreased in the presence of serum,
although to different extent.
EVALUATION OF THE RE-DIFFERENTIATION POTENTIAL
OF IN VITRO-EXPANDED HACs
The re-differentiation potential of the FCS- or SF-
expanded chondrocytes was assayed by micromass
culture. Primary cells were pelleted without any expansionand used as positive controls (Fig. 3, T0). Chondrocytes
expanded in FCS up to ﬁve doublings were not able to re-
differentiate in the 3D-culture system (Fig. 3, middle panel,
left column, FCS). On the contrary, SF-expanded cells
positively stained for cartilage matrix showing metachro-
masie and deposition of proteoglycans (Fig. 3, middle
panel, middle column, SF). TGF b-1 addition during the
expansion phase impaired the re-differentiation process of
the expanded chondrocytes, thus resulting in an uneven
and incomplete matrix deposition in the analyzed pellets
(Fig. 3, middle panel, right column, SFC TGF b-1).
594 P. Giannoni et al.: Chondrocyte expansion from aged patientsFig. 3. Histological analysis of micromass cultures. Cell pellets were prepared from HACs expanded in 10% FCS (left column), SF (middle
column) or SFC TGF b-1 (10 ng/mL; right column) up to ﬁve doublings (5 dbs). Pellets were also prepared from freshly isolated chondrocytes
(T0, upper panel) or from cells expanded for 1 month in FCS and then shifted to SF conditions (FCS/ SF, lower panel). T: Toluidine Blue
staining; S: Safranin-O staining; A: Alcian Blue staining. To minimize bias due to usage of different staining stock solutions, histological
coloration was performed once all the sections were made available after parafﬁn-embedding. Three different HACs were used in the
micromass assays, each one being tested for all the expansion conditions. At least two pellets per culture were processed and two sections
per pellet were stained. The ﬁgure is representative of one experiment out of the three. All pictures were taken at the same magniﬁcation.
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substitution of FCS with SF supplement allowed a clear
recovery of the proliferation rate of the cells. However, this
change of medium was not favorable for the maintenance of
the chondrogenic potential. In those cells, the re-differen-
tiation process was only partially restored since the inner
portion of the pellets did not stain positively for cartilage
matrix (Fig. 3, bottom panel, middle column, SF). In those
cells, the addition of TGF b-1 during the proliferation phase
completely abolished the chondrogenic potential (Fig. 3,
bottom panel, right column, SFC TGF b-1). Immunohisto-
chemical analysis of the micromass cultures conﬁrmed type
II collagen deposition in the matrix of SF-expanded
chondrocytes (Fig. 4). Type I collagen was also present in
the pellets derived both from the SF- and FCS-cultured
chondrocytes, but its expression was limited to the
peripheral layer (Fig. 4, type I collagen, arrow). No
expression of type X collagen was ever evidenced in the
micromass cultures, regardless of the expansion condition
(data not shown).
MMP-3 EXPRESSION LEVELS IN THE
IN VITRO-EXPANDED HACs
MMP-3 mRNA levels were already postulated as de-
pendent upon the age and health status of the donor(s)12.
The relative expression of MMP-3 levels were investigated
by means of real-time RT-PCR, zymographic analysis and
Western blotting in chondrocytes derived from the same
biopsy and expanded in both culturing conditions, SF and
FCS. As shown in Fig. 5(A), culture in the presence ofserum clearly induces a strong up-regulation of the
transcript levels (approximately 15-fold), as compared to
the ones detected in the cells of the same donor but
cultured in SF. The differences between the MMP-3
transcripts in SF and FCS are also reﬂected at the protein
level in the zymographic analysis; on freshly non-concen-
trated medium, a much larger proteinase effect is seen at
the expected position of the activated form of the protein
(48 kDa) in the sample collected from the FCS-cultured
cells [Fig. 5(B)]. Such an induction of MMP-3 by FCS is
down-regulated by the addition of TGF b-1 or RA to the
culture medium, as depicted in Fig. 5(C) and (D). This
observation goes in line with previous reports where these
substances have been shown to modulate MMP-3
expression19,20.
Discussion
Articular cartilage displays a limited repair capacity after
chronic and/or acute injuries. Cartilage lesions do not heal
spontaneously and often undergo progressive degenera-
tion2. In young subjects, trauma is the primary cause of
articular cartilage damage, even though arthroscopic knee
joint examination, aside of trauma, often detects ﬁbrillation,
ﬁssures, clefts and fractures21. The progression of chondral
lesions towards more severe pathologies, such as OA is not
inevitable22 but it is not easily predictable as it depends on
the joint site where the damage occurred23, the duration of
the progression period and the quality of the healing
tissue24. Any therapeutic attempt should provide to the
patients a functional cartilage for the prosecution of a normalFig. 4. Immunohistochemical analysis of micromass cultures for type I and type II collagen expression after expansion in monolayer in FCS or
SF conditions. The arrow indicates the radial limit of type I collagen deposition in the pellets. At least two pellets per culture were processed
and two sections per pellet were stained. The ﬁgure is representative of one experiment out of three. All pictures were taken at the same
magniﬁcation.
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Fig. 5. (A): MMP-3 expression analysis: quantitative real-time RT-PCR. The MMP-3 mRNA level was assessed on three different HACs in the
two culture conditions, FCS (ﬁlled bar) and SF (dashed bar), using six and ﬁve duplicates of each mRNA sample for MMP-3 and GAPDH,
respectively. Calibration curves and normalization to the GAPDH housekeeping gene were used to compare all data. Standard deviations for
each culture conditions are indicated. (B): Zymogram assay for MMP-3 in culture media. The putative zymographic trace of the MMP-3 active
form was assessed in spent medium of FCS or SF-cultured chondrocytes. The metalloproteinase activity is evidenced at 48 kDa. The analysis
was performed on three different HACs. One representative image is shown. Molecular weight markers (kDa) are indicated on the right side of
the panel. (C): Western Blot analysis for MMP-3 in culture media. Electrophoretic separation and Western blotting of conditioned medium of
HACs grown in FCS in the absence () or presence (C) of RA (500 nM) for 7 days. Molecular weight markers (kDa) are indicated on the right
side of the panel. The experiments were repeated on two different HACs. One representative image is shown. (D): Zymogram assay for MMP-
3 in culture media of HACs cultured in FCS in the absence () or presence (C) of 10 ng/mL TGF b-1. Molecular weight markers (kDa) are
indicated on the right side of the panel. Experiments were performed on two different HACs. One representative image is presented.life and physical activities, possibly for decades. Indeed,
ﬁbrocartilage formation still represents a frequent undesired
outcome for ACI treatments25,26. For aged patients, proper
therapies are more complicated due to a general de-
terioration of the cartilage tissue, a size broadening of the
lesion dimensions and a well-documented reduced re-
sponse of the cells to ex-vivo expansion10,11. Although
elderly patients (O65 years of age) should represent the
main target of cartilage repair attempts, cell-based clinical
trials have been aimed to much younger patients whosechondrocytes, at variance with older subjects, can be
readily expanded in vitro. The last published trials reported
an average age comprised between 31 and 37 years, the
oldest patients being 53 years old8,27,28. We therefore
aimed the present study to determine if SF-culture
conditions could: (1) sustain the proliferation of chondro-
cytes from aged donors; (2) maintain during ex-vivo
expansion the chondrogenic potential of those ‘‘aged’’ cells
in view of their therapeutic use. A similar approach,
although with a different medium, was already presented
597Osteoarthritis and Cartilage Vol. 13, No. 7in the literature, but it proved efﬁcient only for cells derived
from pre-puberal donors29. Parallel cultures were performed
in bovine serum, which is widely used in literature as
a normal substitute and is considered to be equivalent to
the human one29. Our choice not to use autologous serum
was also undertaken to avoid any additional request of
blood withdrawal from patients who were undergoing an
invasive procedure such as total knee arthroplasty.
Considering the dimensions of cartilage biopsies (few
milligrams of fresh tissue) and the low number of primary
cells usually obtained, several cell duplications are re-
quired to quantitatively fulﬁll transplantation needs for ACI
protocols.
In previous reports, we have shown in one hand that
chondrocytes from aged or OA patients do not proliferate in
vitro as compared to chondrocytes from young patients13
and in the other hand that the expansion rate of those
‘‘young’’ chondrocytes can be further stimulated if the
serum is substituted by a deﬁned medium12. We here report
that chondrocytes from aged donors, when expanded in SF
conditions, reach the same number of duplications as their
FCS-cultured counterparts but with an overall gain of time of
almost 2 months. This effect of the SF medium is clearly
a technical advantage that reduces time of culture and
related risks, and shortens the patient waiting period before
implantation.
It is also well known that, regardless of the culture
medium, chondrocytes expanded ex-vivo undergo pheno-
type changes; the expression of several chondrogenic
markers being strongly modulated according to the duration
of the expansion phase13,30e32. In addition, progressive cell
senescence diminishes the synthetic activity and respon-
siveness of the cells to mechanical stimuli and growth
factors10,11. Moreover, senescence and/or excessive num-
ber of duplications may lead to telomere shortening33. No
direct evidence has been produced so far to correlate these
events with a diminished chondrogenic commitment or with
a loss of differentiation potential. Nonetheless it is tempting
to speculate that our SF medium may exert a selective and
priming effect on the cells able to de-differentiate and then
re-differentiate but this hypothesis needs to be proven
experimentally. In this respect also FCS-cultured chondro-
cytes seem to maintain responsiveness to medium changes
when they are transferred to SF conditions, but serum
exposure hinders the chondrogenic differentiation potential,
as shown by the failure of the micromass pellets to reform
cartilaginous structures.
The decrease of Sox9 mRNA levels observed in FCS
cultures could be responsible, at least in part, for the
inefﬁcient 3D re-differentiation of FCS-expanded chondro-
cytes13, although the role of other factors or cytoskeleton
modiﬁcations may be of relevance34,35. The alterations in
the amounts of mRNA for speciﬁc matrix components
(aggrecan, COMP, type I and II collagens) we detected
during expansion in FCS or SF have been already described
upon extensive cell growth in monolayer13,30,32,36. Never-
theless the modiﬁcations we here described may reﬂect
a faster de-differentiation of the SF-cultured chondrocytes
as compared to those expanded in FCS. In particular,
COMP transcripts are lost after 5e7 weeks36 in FCS
cultures but already within 3 weeks in SF conditions
(Fig. 2). Addition of TGF b-1 partially restores the normal
level of COMP mRNA, which keeps in line with the growth
factor-mediated expression of this member of the thrombo-
spondin family37. Additionally, Sox9-responsive elements
were already identiﬁed on the COMP mouse promoter38. In
our SF results, though, COMP down-regulation does notseem related to the Sox9 transcript level, which suggests
that other factors may participate in the control of this
extracellular matrix component. As a whole, chondrocyte
exposure to TGF b-1 during the proliferative phase, although
positively regulating the expression of speciﬁc cartilage
proteins, contributes to hindering the differentiation poten-
tial; these results are in agreement with previous reports that
evidence different, if not opposite, effects of TGF b-1
according to the cell maturation status39e41. The residual
collar-like type I collagen positive zone also suggests
a differentiation gradient of the cells in 3D, possibly
mediated through the neo-synthesized extracellular matrix.
The ability of the aged expanded cells to produce
a cartilaginous matrix in vitro is even more drastically
reduced by serum presence, even if for a limited exposure.
The mechanisms by which serum exerts its effects are at
present not deﬁned. Indeed, autocrine/paracrine mecha-
nisms, the physio-pathological condition of the articular
tissue, and the age and health status of the patient
contribute to cartilage homeostasis. In this respect, cartilage
pathological alterations unbalance the expression of speciﬁc
MMPs42e45. Interestingly, the absence of MMP-3 expres-
sion in cartilage specimens from young healthy adults12,46
and in explant models of nasal bovine cartilage47 rules out
MMP-3 participation in the normal chondrocyte-mediated
proteoglycan degradation and in the matrix homeostasis
control. In vivo models of partial-thickness articular defects
evidenced that focal synthesis of MMP-1, -3, and -14
occurred at the lesion site at late time (more than 6 weeks
after injury) during the reparative synthesis. Proteolysis of
damaged matrix has to take place to support the integration
between repaired tissue and surrounding cartilage48, but in
healthy cells and explants MMP-3 seems to be involved only
during late remodeling of the repaired tissue. By contrast,
various studies have evidenced the pivotal role played by
MMP-3 in cartilage inﬂammatory events in vitro49 and in
aging-related OA onset in vivo50e52. Stromelysin-1 knockout
mice do not show immunolocalization of speciﬁc MMP-3
cleavage epitopes, although inﬂammation and proteoglycan
depletion are comparable to wild-type mice. Interestingly,
these mice do not show immune complex arthritis53. On the
other hand, in the antigen-induced arthritis (AIA) model
mice, the fast and marked proteoglycan depletion coincides
with accelerated expression of MMP-induced neo-epitopes,
which correlates with increased levels of latent enzyme in
cartilage before the induction of a ﬂare up54. Being our
biopsies derived from elderly patients, we expected variable
MMP-3 levels, depending on the patient’s articular cartilage
conditions. Nonetheless, the high increase in MMP-3 mRNA
detected in FCS-expanded chondrocytes, as compared to
the SF-cultured ones, points out the need for a careful
examination of the effects of serum presence in the culture
conditions: clearly, transplantable chondrocytes with high
activated MMP-3 levels may be detrimental to a proper
restoration of a functional cartilage at the lesion site,
possibly inducing secondary arthritis phenomena by antigen
rechallenge. To avoid this effect, several factors could be
used to modulate the metalloproteinases: in fast proliferating
cells, RA administration inhibits MMP-3 expression19,55, but
as for chondrocytes, the extent of inhibition may vary
depending on cell environment, i.e., its physio-pathological
status56. Moreover, TGF b-1 also down-modulates MMP-3
levels20,57,58, as conﬁrmed here by our zymographic and
Western blot observations. As already indicated, though,
TGF b-1 reduces the chondrogenic potential of cultured
cells, thereby precluding its usage in a deﬁned medium
during the expansion phase. It is worth mentioning that the
598 P. Giannoni et al.: Chondrocyte expansion from aged patientsfree-radical scavenger antioxidant N-acetylcysteine can
suppress the Tumour Necrosis Factor (TNF)-alpha induction
of stromelysin59, while dexamethasone administration
produced the same effect in a rabbit model of interleukin-1
(IL-1)-induced arthritis60, and polyunsaturated fatty acid
supplementation reduced the expression of mRNAs for
a disintegrin and metalloproteinase with a thrombospondina
motif (ADAMTS-4), MMP-13, and MMP-361. We may thus
postulate that speciﬁc medium components, in our culture
conditions, have a protective role, preventing the cells from
entering a ‘‘pseudo-inﬂammatory’’ status. This condition, if
sustained by a non-stressed (i.e., young) cell and if localized
in a healthy microenvironment, still allows recovery due to
the chondrocyte plasticity and to their differentiation
potential, the outcome being a repaired (or partially repaired)
functional tissue, as seen in young patients4,8. On the
contrary, if the transplantable chondrocytes are aged and
their microenvironment has already undergone partial
deterioration, the activation of a pseudo-inﬂammatory status
may represent the unbalancing factor that compromises any
attempt of tissue repair at the lesion site, possibly triggering
the onset of more severe pathological conditions. Thus, SF-
culture conditions provide: (1) clear advantages in culture
time requirements; (2) physiological absence of serum; (3)
maintenance of the chondrogenic potential; (4) persistence
of normal levels of speciﬁc MMPs. As a whole, only the SF
expansion seems suitable to sustain proper proliferation and
re-differentiation of expanded chondrocytes, particularly if
the cells are provided by aged patients. Therefore,
chondrocyte culturing in an SF medium represents a proper
approach to cell-based therapies for the resolution of focal or
more extended lesions in the articular cartilage of elderly
patients. This implies that ACI could be offered not solely to
young patients, as nowaday, but also to aged subjects who
represent the largest group of patients in need of cartilage
resurfacing.
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